VINEETLAB36.00

Vineet Laboratories Limited

· Pharma & Health
AnnualQuarterly₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.2 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Revenue from Operations150.675.059.4
Other Income0.52.00.1
Total Income151.177.059.5
Expenses
+ Cost of Materials Consumed131.763.861.9
+ Changes in Inventories-17.86.5-23.3
+ Employee Benefit Expense6.45.34.1
+ Finance Costs4.84.04.9
+ Depreciation & Amortisation2.52.52.4
+ Other Expenses23.115.78.2
Total Expenses150.797.858.2
EBITDA7.2-16.38.5
EBIT4.7-18.86.1
Profit
PBT before Exceptional Items0.4-20.81.3
Pretax Income0.4-20.81.3
+ Current Tax-0.10.00.0
+ Deferred Tax-0.6-0.60.2
Tax Expense-0.7-0.60.2
Net Income1.0-20.21.6
+ Net Income — Continuing Ops1.0-20.21.1
+ Net Income — Discontinued Ops0.00.00.5
+ Other Comprehensive Income0.00.10.0
Total Comprehensive Income1.0-20.11.6
Per Share
Basic EPS1.11-21.901.00
Diluted EPS1.11-21.901.00
Continuing & Discontinued Operations
+ Discontinued Operations — before Tax0.00.00.7
+ Tax — Discontinued Operations0.00.00.2
Other Comprehensive Income — detail
+ Other Comprehensive Income0.1
+ Items NOT to be Reclassified to P&L0.2
+ Tax on Items NOT to be Reclassified0.0
Per Share — as-filed variants
Basic EPS — Continuing Operations1.11-21.901.00
Diluted EPS — Continuing Operations1.11-21.901.00
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit36.74.820.8
Gross Margin %24.356.3435.00
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)0.4-20.81.3
Net Income Adj (tax-effected)1.0-20.21.6
EPS Adj1.11-21.901.00
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Filed Debt Equity0.030.01
Filed Dscr-0.000.00
Paid Up Equity Capital9.29.219.2
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.